← Eichor
Condition: Gynecological Malignant Tumor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Gynecological Malignant Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors
Phase 2 · 2 location(s) · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · NCT07448922
Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies
EARLY_Phase 1 · 1 location(s) · Obstetrics & Gynecology Hospital of Fudan University · NCT07434284
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo
Phase 2 · 1 location(s) · Amplexd Therapeutics, Inc. · NCT07572396
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT05647109
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer
Phase 2 · 1 location(s) · Mayo Clinic · NCT06855524
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05053230
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecolo
Phase 2 · 3 location(s) · Emory University · NCT06492070
Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract
NA · 1 location(s) · CNAO National Center of Oncological Hadrontherapy · NCT05478876
Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Seconda
Phase N/A · 1 location(s) · Bernardino Clavo, MD, PhD · NCT06816095
A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB
Phase N/A · 2 location(s) · Sun Yat-sen University · NCT06781151
Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy
NA · 1 location(s) · Chongqing University Cancer Hospital · NCT05793749
A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gyneco
Phase 2 · 1 location(s) · Shanghai Henlius Biotech · NCT06769152
Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies
NA · 1 location(s) · CNAO National Center of Oncological Hadrontherapy · NCT05457595
Adaptive Radiotherapy in Patients With Gynecological Tumors
NA · 1 location(s) · University Hospital, Essen · NCT06230549
Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy
Phase N/A · 1 location(s) · Viome · NCT04957511
Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neopla
NA · 1 location(s) · PCK Marine Hospital in Gdynia · NCT06574087
Evaluation of the Subjectively Perceived Pelvic Floor Function in Patients With Gynecological Tumors and Breast Cancer U
Phase N/A · 1 location(s) · St. Josefs-Hospital Wiesbaden GmbH · NCT04655066
Identifying Genetic Targets in Gynecological Tumors
Phase N/A · 1 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT07169396
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
Phase 2 · 4 location(s) · University of Oklahoma · NCT05512208
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
Phase 1/Phase 2 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT05803018
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.